Immunovant, Inc. (NASDAQ:IMVT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 06, 2026. The Healthcare company reported Q0 revenue…
Immunovant, Inc. (NASDAQ:IMVT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 06, 2026.
The Healthcare company reported Q0 revenue of .
Immunovant, Inc.'s stock currently trades at $27.05 with a market capitalization of $4.4B.
Current market data
NASDAQ · IMVT
$42.60
Down: -$0.26 · -0.60%
Live quote updated
Keep reading
earnings ·
sec_filing ·
analyst ·
institutional ·
